| 2D Structure | |
| CID | 795 |
| IUPAC Name | 1H-imidazole |
| InChI | InChI=1S/C3H4N2/c1-2-5-3-4-1/h1-3H,(H,4,5) |
| InChI Key | RAXXELZNTBOGNW-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C3H4N2 |
| Molecular Weight | 68.08 |
| synonyms | ['imidazole', '1H-Imidazole', '288-32-4', 'Glyoxaline', 'Imidazol', 'Iminazole', 'Miazole', '1,3-Diazole', 'Imutex', 'Glyoxalin', '1,3-Diaza-2,4-cyclopentadiene', 'Pyrro(b)monazole', 'Glioksal', "Formamidine, N,N'-vinylene-", 'Pyrro[b]monazole', "Methanimidamide, N,N'-1,2-ethenediyl-", 'DTXSID2029616', "N,N'-vinyleneformamidine", '7GBN705NH1', "N,N'-1,2-ethenediylmethanimidamide", 'NSC-60522', 'DTXCID809616', 'CHEBI:16069', 'RefChem:5902', 'CHEBI:14434', '206-019-2', 'USAF EK-4733', 'Glioksal [Polish]', 'IMD', 'CCRIS 3345', 'AI3-24703', 'MFCD00005183', 'NSC 60522', 'BRN 0103853', 'CHEMBL540', '1H-imidazol', '227760-40-9', 'CAS-288-32-4', 'Imidazole (8CI)', 'NSC51860', 'Imidazole, puriss. p.a., >=99.5% (GC)', 'EINECS 206-019-2', 'NSC 51860', 'UNII-7GBN705NH1', 'Immidazole', 'imidazole-', 'Imidazole CRS', '1-H-imidazole', 'Glyoxaline solution', 'Imidazole, Reagent', '{Pyrro[b]monazole}', '1,4-cyclopentadiene', 'Imidazole, ACS grade', '1,3-Dia-zole', '1H-Imidazole (9CI)', 'IMIDAZOLE [MI]', 'Imidazole buffer Solution', "Formamidine,N'-vinylene-", 'SCHEMBL818', 'SCHEMBL897', 'bmse000096', 'bmse000790', 'WLN: T5M CNJ', 'EC 206-019-2', 'ENALAPRIL IMPURITY I', 'Ondansetron impurity E CRS', 'IMIDAZOLE [USP-RS]', 'IMIDAZOLE [WHO-DD]', 'SCHEMBL1613', 'SCHEMBL3718', 'SCHEMBL4364', 'NCIStruc1_001975', 'NCIStruc2_000693', 'Imidazole, LR, >=99%', '5-23-04-00191 (Beilstein Handbook Reference)', 'Him', 'MLS001055465', 'SCHEMBL145167', 'SCHEMBL203925', 'SCHEMBL449611', 'SCHEMBL449820', 'SCHEMBL452364', 'SCHEMBL452509', 'BDBM7882', 'orb2300277', 'SCHEMBL1664410', 'SCHEMBL2635292', 'SCHEMBL7472578', 'HSDB 8449', 'MSK5541', '1,3-Diaza-2,4-cyclopentadiene-', 'HMS5085J21', 'Imidazole, ReagentPlus(R), 99%', 'Imidazole, for synthesis, 99.5%', 'GAA74543', 'HY-D0837', 'NSC60522', 'ZCA35070', 'ZCA36246', "Methanimidamide,N'-1,2-ethenediyl-", 'Tox21_201504', 'Tox21_303345', 'EBC-44312', 's6006', 'SBB040815', 'STK362967', 'AKOS000120177', 'CS-5135', 'DB03366', 'FI34308', 'Imidazole, BioUltra, >=99.5% (GC)', 'NCGC00090984-01', 'NCGC00090984-02', 'NCGC00257344-01', 'NCGC00259055-01', 'BP-11451', 'SMR000057825', 'ST097249', 'Imidazole, SAJ special grade, >=99.0%', 'Imidazole, Vetec(TM) reagent grade, 98%', 'DB-002018', 'CLOTRIMAZOLE IMPURITY D [EP IMPURITY]', 'FLUTRIMAZOLE IMPURITY A [EP IMPURITY]', 'I0001', 'I0014', 'I0288', 'I0290', 'Imidazole, >=99% (titration), crystalline', 'NS00001351', 'EN300-19083', 'Imidazole Zone Refined (number of passes:30)', 'Imidazole, ACS reagent, >=99% (titration)', 'C01589', 'P17516', 'ENALAPRIL MALEATE IMPURITY I [EP IMPURITY]', 'F021690', 'Q328692', 'J-200340', 'SILDENAFIL CITRATE IMPURITY E [EP IMPURITY]', 'Bifonazole EP Impurity C(Clotrimazole EP Impurity D)', 'Imidazole, for molecular biology, >=99% (titration)', 'F2190-0638', 'Z104472692', 'Imidazole, BioUltra, for molecular biology, >=99.5% (GC)', 'Imidazole, European Pharmacopoeia (EP) Reference Standard', '4286D518-643C-4C69-BCE7-519D073F4992', 'Imidazole, United States Pharmacopeia (USP) Reference Standard', 'InChI=1/C3H4N2/c1-2-5-3-4-1/h1-3H,(H,4,5', 'Imidazole;1,3-diazole; glyoxaline; 1,3-diazacyclopenta-2,4-diene', 'ONDANSETRON HYDROCHLORIDE DIHYDRATE IMPURITY E [EP IMPURITY]', 'ONDANSETRON HYDROCHLORIDE IMPURITY, IMIDAZOLE- [USP IMPURITY]', 'Imidazole, anhydrous, free-flowing, Redi-Dri(TM), ACS reagent, >=99%', 'Imidazole, Pharmaceutical Secondary Standard; Certified Reference Material', 'Ondansetron impurity E, European Pharmacopoeia (EP) Reference Standard', 'Ondansetron EP Impurity E; Sildenafil EP Impurity E; Clotrimazole EP Impurity D; Enalapril Maleate EP Impurity I; Bifonazole EP Impurity C; Flutrimazole EP Impurity A'] |
From Pubchem